Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database

NCT02897908 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.

NCT NCT02897908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02897908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-invasive Liver Screening Using FibroScan Device for Liver Disease Patients for the Steatosis/Fibrosis Database
Lead sponsor
State University of New York at Buffalo
Phase
Observational
Overall status
Recruiting
Start date
October 28, 2016
Completion date
April 30, 2027
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

disease of liver and bile duct